Cargando...
Engineered Cytokine Signaling to Improve CAR T Cell Effector Function
Adoptive immunotherapy with T cells genetically modified to express chimeric antigen receptors (CARs) is a promising approach to improve outcomes for cancer patients. While CAR T cell therapy is effective for hematological malignancies, there is a need to improve the efficacy of this therapeutic app...
Gardado en:
| Publicado en: | Front Immunol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220823/ https://ncbi.nlm.nih.gov/pubmed/34177932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.684642 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|